From the Journals
From the Journals
Dabigatran, rivaroxaban linked to slight increase in GI bleeding risk
Overall, the risk of major bleeds associated with NOACs was similar to the risk with conventional anticoagulants.
From the Journals
VIDEO: Alcohol showed no cardiovascular benefits in nonalcoholic fatty liver disease
Long-term prospective studies are needed to better understand how types and doses of alcohol affect cardiovascular endpoints in patients with...
News
FDA approves first non–finger-stick glucose monitoring system
One thin wire can provide reliable blood glucose readings in a new glucose meter newly granted FDA approval.
Latest News
No benefit seen for routine low-dose oxygen after stroke
The large SO2S trial found no benefit for continuous or night-only routine oxygen supplementation.
From the Journals
Battling physician burnout delivers monetary benefits for health care organizations
Organizations can combat physician burnout, and the effort is worthwhile, as well as morally and ethically important.
From the Journals
Can arterial switch operation impact cognitive deficits?
Cognitive effects common among adults who had transposition of the great arteries.
From the Journals
Statin use reduces death and decompensation in cirrhosis patients
More statins, more positive outcomes.
From the Journals
Rheumatoid arthritis characteristics make large contribution to cardiovascular risk
RA characteristics had a larger effect on women’s risk than on men’s.
From the Journals
Statins linked to lower death rates in COPD
Researchers explore whether COPD progression results from systemic inflammation.
From the Journals
Riociguat may benefit subset of PAH patients
Some improvements were seen in pulmonary arterial hypertension patients who switched to using riociguat from phosphodiesterase-5 inhibitors.
From the Journals
Patent foramen ovale closure reduces risk of stroke in three trials
Risks of procedure must be weighed against the benefit of reduced stroke risk.